🇩🇪 Germany Country × Condition
vascular diseases Clinical Trials in Germany
Active clinical trials for vascular diseases with research sites in Germany. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇩🇪 Germany
Active Trials in Germany (2)
NCT03934957
Recruiting
Hamburg City Health Study - a German Cohort Study
Enrollment
45,000 pts
Country
🇩🇪 Germany
Universitätsklinikum Hamburg-Eppend...
View Trial → NCT07115953
Recruiting
Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
Enrollment
130 pts
Country
🇩🇪 Germany
Medtronic Vascular
View Trial → Frequently Asked Questions
How many vascular diseases clinical trials are active in Germany?
There are currently 2 active clinical trials for vascular diseases with sites in Germany, of which 2 are actively recruiting patients.
How can I join a vascular diseases clinical trial in Germany?
To join a vascular diseases clinical trial in Germany, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Germany directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are vascular diseases trials in Germany?
Active vascular diseases trials in Germany span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology